Australia’s medtech conference, AusMedtech 2019, is on track to deliver a notable 50/50 split within its programme of speakers and chairs. The Australian medtech sector holds some of the world’s leading innovative companies, and AusBiotech is proud to showcase the diversity of thought leaders across them.
With the theme ‘Bionics and beyond’, the AusMedtech 2019 presents an engaging line up of keynote speakers and knowledgeable panellists who will share their expertise, insight and commentary on a range of topics both practical and inspirational.
AusBiotech CEO Lorraine Chiroiu says, “AusBiotech is committed to diversity and inclusion. Underpinning diversity within our work allows us to highlight different perspectives and insights, including in male-dominated areas, such as investment. We are looking forward to hearing three (of five) female investor panellists reverse-pitch at AusMedtech 2019.”
The Investors: Through the looking-glass session asks leading investors to give six-minute pitches on why companies should choose them over their colleagues as the source of their next funding. The reverse-pitches will be followed by free-flowing a Q&A.
Panellists include Amanda Gillon, COO Investments – BioScience Managers; Natasha Rawlings, Investment Manager – Uniseed; Jarred Shein, Investment Manager – Qure Ventures; Ingmar Wahlqvist, Investment Manager – Brandon Capital Partners; and Renee Compton Ryan, Vice President Venture Investments – Johnson & Johnson Development Corporation.
AusMedtech 2019 is the perfect opportunity to connect with like-minded leaders growing the Australian and global medtech industry to ultimately benefit people around the world. The conference is being held in Melbourne on 14-15 May, in partnership with the Victorian Government. Read the programme and register here.